All News
Filter News
Found 806,263 articles
-
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021
2/18/2021
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will report fourth quarter and full year 2020 financial results and provide a corporate update before market open on Thursday, February 25, 2021.
-
Agadia Systems, Inc. Announces Agreement with Blue Cross and Blue Shield of Kansas City for use of Agadia's Electronic Prior Authorization Solution, PAHub™
2/18/2021
Agadia Systems, Inc. (Agadia), a recognized healthcare technology solution provider for Health Plans & PBMs is announcing an agreement with Blue Cross and Blue Shield of Kansas City (Blue KC), to utilize PAHub, Agadia's HITRUST certified, end-to-end Electronic Prior Authorization management solution.
-
Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
2/18/2021
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it will release its fourth quarter and full year 2020 financial results after the market closes on Thursday March 4, 2021.
-
AVITA Medical to Present at Upcoming Investor Conferences
2/18/2021
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the following upcoming investor conferences:
-
Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
2/18/2021
Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that Pablo J. Cagnoni, M.D., president and chief executive officer, and the executive management team will participate in a fireside chat at the 10 th Annual SVB Leerink Global Healthcare Conference on February 25,2021
-
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
2/18/2021
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a conference call at 8:00 AM EDT on February 24, 2021, to discuss its fourth quarter 2020 results and provide a business update
-
Somru BioScience and Veeda Clinical Research Announce Joint Venture Global Biotherapeutic Contract Research Organization (CRO) in India
2/18/2021
Ingenuity BioSciences Pvt. Ltd – Veeda Clinical Research, one of India’s leading and largest independent CRO companies, and Somru BioScience Inc., a leading Canadian-based biotechnology company based in Charlottetown, Prince Edward Island, are proud to announce the establishment of an innovation-centric bioanalytical laboratory in Ahmedabad, India.
-
Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference
2/18/2021
Quanterix Corporation (NASDAQ: QTRX) , a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executive Officer and President, Kevin Hrusovsky, will be presenting at the 10 th Annual SVB Leerink Global Healthcare Conference, being held virtually from February 22 – 26, 2021.
-
Codexis to Present at Upcoming Virtual Healthcare Conferences
2/18/2021
Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will present at three upcoming virtual investment conferences.
-
Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
2/18/2021
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a conference call and webcast on Thursday, March 4, 2021, at 8:30 a.m. ET to discuss fourth quarter and year-end 2020 financial results and provide a general business update.
-
KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
2/18/2021
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 9:20 a.m. ET.
-
Xeris Pharmaceuticals to Webcast Upcoming Investor Conference Presentations
2/18/2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, will present an overview of the Company at the following upcoming investor conferences:
-
Appili Therapeutics to Host Series of Virtual Fireside Chats; First Event to Feature Dr. Scott Gottlieb to Discuss Critical Need for More Options to Combat COVID-19
2/18/2021
Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced its first webinar series examining major trends in the global infectious disease landscape
-
Gilead Sciences to Present at Upcoming Investor Conferences
2/18/2021
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:40 p.m. EST Cowen Annual Health Care Conference on Thursday, March 4, 2021 at 12:10 p.m. EST
-
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2020 Results
2/18/2021
Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2020 results
-
Dicerna to Report Full Year 2020 Financial Results on Feb. 25, 2021
2/18/2021
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its financial results for the full year ended Dec. 31, 2020 after market close on Thursday, Feb. 25, 2021.
-
AscellaHealth and ShareSource Partner to Present 2021 Webinar: Driving a Successful Specialty Pharmacy Strategy for Providers, Hospitals and Health-Related Institutions
2/18/2021
AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, has partnered with The Healthcare Council, an organization of Providers of Care consisting of hospitals and allied health care facilities serving Virginia, Maryland and the District of Columbia, and expanding regions, and its subsidiary corporation ShareSource, to present a virtual education webinar:
-
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
2/18/2021
- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, today announced that Rahul Kakkar, M.D., Chief Executive Officer of Pandion Therapeutics, will present at the upcoming 10 th Annual SVB Leerink Healthcare Conference on Thursday, February 25, 2021, at 9:20 a.m. ET.
-
Zogenix to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
2/18/2021
Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, Ph.D., will participate in a fireside chat on Friday, February 26, 2021, at the 10th Annual SVB Leerink Global Healthcare Conference.
-
Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
2/18/2021
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that management will be participating in the following virtual investor events in March: Cowen 41 st Annual Health Care Conference – March 1-4, 2021.